ArticleCells2024

Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer.

Immacolata Maietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.